Psychotropic analgesic nitrous oxide for acute cocaine withdrawal in man

International Journal of Neuroscience

Volumn 116, Issue 7, 2006, Pages 847-857

  Gillman, Mark ^a   Lichtigfeld, Frederick ^a   Harker, Nadine ^b  

^a South African Brain Research Institute   (South Africa)

^b SANCA PE Mercantile Hospital   (South Africa)

Author keywords

Cocaine withdrawal; Psychotropic analgesic nitrous oxide

Indexed keywords

CARBAMAZEPINE; CYANOCOBALAMIN; ISOPRENALINE; NITROUS OXIDE PLUS OXYGEN; OXAZEPAM; PLACEBO; PSYCHOTROPIC ANALGESIC NITROUS OXIDE; UNCLASSIFIED DRUG; VITAMIN B GROUP;

ADULT; ANXIETY DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHORIA; FEMALE; HUMAN; MALE; OXYGEN THERAPY; SCORING SYSTEM; SINGLE BLIND PROCEDURE; WITHDRAWAL SYNDROME;

ADULT; ANALGESIA, PATIENT-CONTROLLED; ANTI-ANXIETY AGENTS; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; NITROUS OXIDE; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTROPIC DRUGS; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD;

EID: 33746660398     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.1080/00207450600754038     Document Type: Conference Paper

References (34)

1. Alho, H., Methuen, T., Paloheimo, M., Strid, N., Seppa, K., Tiainen, J., Salaspuro, M., & Roine, R. (2002). Long-term effects of and physiological responses to nitrous oxide gas treatment during alcohol withdrawal: A double-blind, placebo-controlled trial. Alcoholism: Clinical Experimental Research, 26, 1816-1822.
2. Alho, H., Metheun, T., Paloheimo, M., Seppä, K., Strid, N., Apter-Kaseva, N., Tiainen, K., Salaspuro, M., & Roine, R. (2003). Nitrous oxide has no effect in the treatment of alcohol withdrawal syndrome: Double-blind placebo-controlled randomized trial. Journal of Clinical Psychopharmacology, 23, 211-214.
3. Anonymous. (2002). Nida Website. Available at http://www.drugabuse.gov/ pdf/infofacts/Cocaine05.pdf (accessed May 20, 2005).
4. Bowman, W. C., & Rand, M. J. (1980). Textbook of pharmacology. 2nd Edition (pp. 42.80-42.82). Oxford: Blackwell.
5. Carey, C., Clark, A., & Saner, A. (1991). Excellent results with analgesic nitrous oxide for addictive withdrawal states in general practice. South African Medical Journal, 79, 516.
6. Clark, M. S., Campbell, S. A., & Clark, A. M. (2006). Technique for the administration of nitrous oxide/oxygen sedation to ensure psychotropic analgesic nitrous oxide (PAN) effects. International Journal of Neuroscience, 116, 871-877.
7. Daynes, G., & Gillman, M. A. (1994). Psychotropic analgesic nitrous oxide prevents craving after withdrawal for alcohol, cannabis and tobacco. International Journal of Neuroscience, 76, 13-16.
8. Dworkin, S. F., Schubert, M., Chen, A. C. N., & Clark, D. W. (1986). Psychological preparation influences nitrous oxide analgesia: Replication of laboratory findings in a clinical setting. Oral Surgery Oral Medicine and Oral Pathology, 61, 108-112.
9. Gillman, M. A. (1986). Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system: A review of the evidence. Life Sciences, 39, 1209-1222.
10. Gillman, M. A., & Lichtigfeld, F. J. (1985). Analgesic nitrous oxide: Adjunct to clonidine for opioid withdrawal. American Journal of Psychiatry, 142, 784-785.
11. Gillman, M. A., & Lichtigfeld, F. J. (1986). Minimal sedation required with nitrous oxide-oxygen treatment of the alcohol withdrawal state. British Journal of Psychiatry, 148, 604-606.
12. Gillman, M. A., & Lichtigfeld, F. J. (1990). Analgesic nitrous oxide for alcohol withdrawal: A critical appraisal after 10 years use. Postgraduate Medical Journal, 66, 543-546.
13. Gillman, M. A., & Lichtigfeld, F. J. (1991a). Placebo and analgesic nitrous oxide for the alcohol withdrawal state. British Journal of Psychiatry, 159, 672-675.
14. Gillman, M. A., & Lichtigfeld, F. J. (1991b). The opioid effects of analgesic (subanesthetic) nitrous oxide on the alcohol withdrawal state. Annals of the New York Academy of Sciences, 625, 784-785.
15. Gillman, M. A., & Lichtigfeld, F. J. (1998). Clinical role and mechanisms of action of analgesic nitrous oxide. International Journal of Neuroscience, 93, 55-62.
16. Gillman, M. A., & Lichtigfeld, F. J. (2002). Randomised double-blind trial of psychotropic analgesic nitrous oxide compared with diazepam for alcohol withdrawal state. Journal of Substance Abuse Treatment, 22, 129-134.
17. Gillman, M. A., & Lichtigfeld, F. J. (2004a). An incorrect technique guarantees failure. Alcoholism: Clinical Experimental Research, 28, 1273-1274.
18. Gillman, M. A., & Lichtigfeld, F. J. (2004b). Correct use of analgesic nitrous oxide for the alcohol withdrawal state essential. Journal of Clinical Psychopharmacology, 24, 238-239.
19. Gillman, M. A., & Lichtigfeld, F. J. (2004c). Enlarged double-blind randomised trial of benzodiazepines against psychotropic analgesic nitrous oxide for alcohol withdrawal. Addictive Behaviors, 29, 1183-1187.
20. Gillman, M. A., & Lichtigfeld, F. J. (2006). Psychotropic analgesic nitrous oxide (PAN) as a probe of the endogenous opioid system inman and for treating substance abuse withdrawal. In L. A. Bennet (Ed.), New Topics in Substance Abuse Treatment, (pp. 1-72). New York: Nova Science.
21. Gross, M., Lewis, E., & Nagarajan, M. (1973). An improved quantitative system for assessing the acute alcoholic psychoses and related states (TSA and SSA). In M. Gross (Ed.), Alcohol intoxication and withdrawal: Experimental Studies, Vol. 35 (pp. 365-376). New York: Plenum Press.
22. Gross, M., Lewis, E., & Hastey, J. (1974). Acute alcohol withdrawal syndrome. In B. Kissin & H. Begleiter (Eds.), The biology of alcoholism, Vol. 3 (pp. 191-256). New York: Plenum Press.
23. Jaffe, J. H. (1990). Opioid analgesics and antagonists. In A. Goodman-Gilman, T. W. Rall, A. S. Nies, & P. Taylor (Eds.), Goodman and Gilman's the pharmacological basis of therapeutics. 8th Edition (pp. 522-573). New York: Pergamon.
24. Kripke, B. J., & Hechtman, H. B. (1972). Nitrous oxide for pentazocine addiction and for intractable pain: Report of case. Anesthesia and Analgesia, 51, 522-527.
25. Lichtigfeld, F. J., & Gillman, M. A. (1982). The treatment of alcoholic withdrawal states with oxygen and nitrous oxide. South African Medical Journal, 61, 349-351.
26. Lichtigfeld, F. J., & Gillman, M. A. (1989a). The effect of placebo in the alcohol withdrawal state. Alcohol and Alcoholism, 24, 109-112.
27. Lichtigfeld, F. J., & Gillman, M. A. (1989b). Analgesic nitrous oxide for alcohol withdrawal is better than placebo. International Journal of Neuroscience, 49, 71-74.
28. Lichtigfeld, F. J., & Gillman, M. A. (1996). Role of dopamine mesolimbic system in opioid action of psychotropic analgesic nitrous oxide (PAN) in alcohol and drug withdrawal. Clinical Neuropharmacology, 19, 246-250.
29. Myles, M. (1992). Managing alcohol withdrawal states with oxygen and nitrous oxide. Nursing R.S.A, 7, 9-10.
30. O'Brien, C. P. (1996). Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, & A. G. Gilman (Eds.), Goodman and Gilman's the pharmacological basis of therapeutics. 9th Edition (pp. 557-577). New York: McGraw-Hill.
31. Ojutkangas, R., & Gillman, M. A. (1994). Psychotropic analgesic nitrous oxide for treating alcohol withdrawal in an outpatient setting. International Journal of Neuroscience, 76, 35-39.
32. Parry, C. D. H., Bhana, A., Pluddermann, A., Myers, B., Siegfried, N., Morojelle, N. K., Flisher, A. J., & Kozell, N. J. (2002). The South African Community Epidemiology Network on Drug Use (SACENDU): Description, findings (1997-1999) and policy implications. Addiction, 97, 969-976.
33. Parry, C. D. H., Bhana, A., Pluddermann, A., Harker, N., Potgieter, H., Gerber, W., & Johnson, C. (2005). Alcohol and drug abuse trends: July-December 2004 (Phase 17) The South African Community Epidemiology Network on Drug Use (SACENDU). Update: May 16, 2005, Available at http://www. sahealthinfo.org/admodule/sac.htm.
34. Searll, A. (1989). It can't happen to me. (pp. 70-80). Cape Town: Struik Publishers.